Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 369

1.

Monoclonal antibodies capable of discriminating the human inhibitory Fcgamma-receptor IIB (CD32B) from the activating Fcgamma-receptor IIA (CD32A): biochemical, biological and functional characterization.

Veri MC, Gorlatov S, Li H, Burke S, Johnson S, Stavenhagen J, Stein KE, Bonvini E, Koenig S.

Immunology. 2007 Jul;121(3):392-404. Epub 2007 Mar 26.

2.

Fc optimization of therapeutic antibodies enhances their ability to kill tumor cells in vitro and controls tumor expansion in vivo via low-affinity activating Fcgamma receptors.

Stavenhagen JB, Gorlatov S, Tuaillon N, Rankin CT, Li H, Burke S, Huang L, Vijh S, Johnson S, Bonvini E, Koenig S.

Cancer Res. 2007 Sep 15;67(18):8882-90. Erratum in: Cancer Res. 2008 Sep 15;68(18):7692. Vijh, Sujata [added].

3.

Therapeutic control of B cell activation via recruitment of Fcgamma receptor IIb (CD32B) inhibitory function with a novel bispecific antibody scaffold.

Veri MC, Burke S, Huang L, Li H, Gorlatov S, Tuaillon N, Rainey GJ, Ciccarone V, Zhang T, Shah K, Jin L, Ning L, Minor T, Moore PA, Koenig S, Johnson S, Bonvini E.

Arthritis Rheum. 2010 Jul;62(7):1933-43. doi: 10.1002/art.27477.

4.

CD32B, the human inhibitory Fc-gamma receptor IIB, as a target for monoclonal antibody therapy of B-cell lymphoma.

Rankin CT, Veri MC, Gorlatov S, Tuaillon N, Burke S, Huang L, Inzunza HD, Li H, Thomas S, Johnson S, Stavenhagen J, Koenig S, Bonvini E.

Blood. 2006 Oct 1;108(7):2384-91. Epub 2006 Jun 6.

5.
6.

A novel polymorphism in the Fcgamma receptor IIB (CD32B) transmembrane region alters receptor signaling.

Li X, Wu J, Carter RH, Edberg JC, Su K, Cooper GS, Kimberly RP.

Arthritis Rheum. 2003 Nov;48(11):3242-52.

7.

Infliximab treatment shifts the balance between stimulatory and inhibitory Fcgamma receptor type II isoforms on neutrophils in patients with rheumatoid arthritis.

Belostocki K, Pricop L, Redecha PB, Aydin A, Leff L, Harrison MJ, Salmon JE.

Arthritis Rheum. 2008 Feb;58(2):384-8. doi: 10.1002/art.23200.

8.

FcgammaR: The key to optimize therapeutic antibodies?

Sibéril S, Dutertre CA, Fridman WH, Teillaud JL.

Crit Rev Oncol Hematol. 2007 Apr;62(1):26-33. Epub 2007 Jan 19. Review.

PMID:
17240158
9.

Cell-specific, activation-dependent regulation of neutrophil CD32A ligand-binding function.

Nagarajan S, Venkiteswaran K, Anderson M, Sayed U, Zhu C, Selvaraj P.

Blood. 2000 Feb 1;95(3):1069-77.

10.

The functional variant of the inhibitory Fcgamma receptor IIb (CD32B) is associated with the rate of radiologic joint damage and dendritic cell function in rheumatoid arthritis.

Radstake TR, Franke B, Wenink MH, Nabbe KC, Coenen MJ, Welsing P, Bonvini E, Koenig S, van den Berg WB, Barrera P, van Riel PL.

Arthritis Rheum. 2006 Dec;54(12):3828-37.

11.
12.

A novel human CD32 mAb blocks experimental immune haemolytic anaemia in FcgammaRIIA transgenic mice.

van Royen-Kerkhof A, Sanders EA, Walraven V, Voorhorst-Ogink M, Saeland E, Teeling JL, Gerritsen A, van Dijk MA, Kuis W, Rijkers GT, Vitale L, Keler T, McKenzie SE, Leusen JH, van de Winkel JG.

Br J Haematol. 2005 Jul;130(1):130-7.

PMID:
15982355
13.

Inhibition of Fcgamma receptor-mediated phagocytosis by a nonphagocytic Fcgamma receptor.

Hunter S, Indik ZK, Kim MK, Cauley MD, Park JG, Schreiber AD.

Blood. 1998 Mar 1;91(5):1762-8.

14.

Expression of functional activating and inhibitory Fcgamma receptors on human B cells.

Rabinovitch N, Gelfand EW.

Int Arch Allergy Immunol. 2004 Mar;133(3):285-94. Epub 2004 Feb 17.

PMID:
14976398
15.

Immunocytochemical detection of Fcgamma receptors in human atherosclerotic lesions.

Ratcliffe NR, Kennedy SM, Morganelli PM.

Immunol Lett. 2001 Jul 2;77(3):169-74.

PMID:
11410250
16.

Immunotherapy targeting inhibitory Fcγ receptor IIB (CD32b) in the mouse is limited by monoclonal antibody consumption and receptor internalization.

Williams EL, Tutt AL, Beers SA, French RR, Chan CH, Cox KL, Roghanian A, Penfold CA, Butts CL, Boross P, Verbeek JS, Cragg MS, Glennie MJ.

J Immunol. 2013 Oct 15;191(8):4130-40. doi: 10.4049/jimmunol.1301430. Epub 2013 Sep 11.

17.

Differential recruitment of activating and inhibitory Fc gamma RII during phagocytosis.

Syam S, Mero P, Pham T, McIntosh CA, Bruhns P, Booth JW.

J Immunol. 2010 Mar 15;184(6):2966-73. doi: 10.4049/jimmunol.0900016. Epub 2010 Feb 12.

18.

Synthesis and receptor binding of IgG1 peptides derived from the IgG Fc region.

Uray K, Medgyesi D, Hilbert A, Sármay G, Gergely J, Hudecz F.

J Mol Recognit. 2004 Mar-Apr;17(2):95-105.

PMID:
15027030
19.

Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions.

Boruchov AM, Heller G, Veri MC, Bonvini E, Ravetch JV, Young JW.

J Clin Invest. 2005 Oct;115(10):2914-23. Epub 2005 Sep 15.

20.

Fc gamma receptor IIB on dendritic cells enforces peripheral tolerance by inhibiting effector T cell responses.

Desai DD, Harbers SO, Flores M, Colonna L, Downie MP, Bergtold A, Jung S, Clynes R.

J Immunol. 2007 May 15;178(10):6217-26.

Supplemental Content

Support Center